Frailty Poses No Limit to HFpEF Meds : comparemela.com

Increased frailty of patients with heart failure with preserved ejection fraction should have no bearing on whether those patients receive sacubitril/valsartan, according to results of a data analysis.

Related Keywords

Zagreb , Grad , Croatia , Copenhagen , Køavn , Denmark , Barcelona , Comunidad Autonoma De Cataluna , Spain , Georgea Heckman , Maja Cikes , Kenneth Rockwood , University Of Waterloo Canada , Journal Of The American College Cardiology , European Society Of Cardiology , Drug Administration , Dalhousie University In Halifax , University Hospital Center Zagreb , Copenhagen University Hospital , European Society , American College , Valsartan Because , Copenhagen University , Without Increasing , Dalhousie University , Heart Failure , Frailty , Frailty Syndrome , Elderly Concerns Of Older Adults , Meta Analysis , Hospitals , Inpatient Care , Drug Treatment Safety , Ejection Fraction Ef , Eft Ventricular Ejection Fraction Lvef , Geriatrics Elder Care , Medical Literature , Books , Textbooks , Ournals , Patient Safety ,